Meryl Altree

发表

Methionine-Dependence Phenotype in the de novo Pathway in BRCA1 and BRCA2 Mutation Carriers with and without Breast Cancer

M. Fenech, J. Turner, V. Dhillon, 2008, Cancer Epidemiology Biomarkers & Prevention.

Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomalies.

E. Haan, L. Hinton, G. Sutherland, 2002, American journal of medical genetics.

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.

Anna L. Brown, T. Walsh, M. King, 2016, Blood.

Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia

Anna L. Brown, Ian D. Lewis, Sarah Moore, 2011, Nature Genetics.

Detection Of Chromosomal Instability And Subtelomeric Rearrangements In Sick Neonate And Children With Multiple Congenital Malformations

E. Haan, L. Shaffer, L. Hinton, 2015 .

RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.

Anna L. Brown, Paul P. S. Wang, S. Fröhling, 2020, Blood advances.

Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.

M. Fenech, J. Turner, S. Beetstra, 2006, Carcinogenesis.

GATA2 is a New Predisposition Gene for Familial Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Anna L. Brown, K. Friend, P. Ekert, 2010 .

Methionine-Dependence Phenotype in the de novo Pathway in BRCA1 and BRCA2 Mutation Carriers with and without Breast Cancer

M. Fenech, J. Turner, V. Dhillon, 2008, Cancer Epidemiology Biomarkers & Prevention.